PUBLIC LAW 109–417—DEC. 19, 2006
120 STAT. 2841
‘‘(B) SEPARATE ACCOUNTING.—Each failure described in subparagraph (A) or (B) of paragraph (5) shall be treated as a separate failure for purposes of calculating amounts withheld under subparagraph (A). ‘‘(7) REALLOCATION OF AMOUNTS WITHHELD.— ‘‘(A) IN GENERAL.—The Secretary shall make amounts withheld under paragraph (6) available for making awards under section 319C–2 to entities described in subsection (b)(1) of such section. ‘‘(B) PREFERENCE IN REALLOCATION.—In making awards under section 319C–2 with amounts described in subparagraph (A), the Secretary shall give preference to eligible entities (as described in section 319C–2(b)(1)) that are located in whole or in part in States from which amounts have been withheld under paragraph (6). ‘‘(8) WAIVE OR REDUCE WITHHOLDING.—The Secretary may waive or reduce the withholding described in paragraph (6), for a single entity or for all entities in a fiscal year, if the Secretary determines that mitigating conditions exist that justify the waiver or reduction. ‘‘(h) GRANTS FOR REAL-TIME DISEASE DETECTION IMPROVEMENT.— ‘‘(1) IN GENERAL.—The Secretary may award grants to eligible entities to carry out projects described under paragraph (4). ‘‘(2) ELIGIBLE ENTITY.—For purposes of this section, the term ‘eligible entity’ means an entity that is— ‘‘(A)(i) a hospital, clinical laboratory, university; or ‘‘(ii) a poison control center or professional organization in the field of poison control; and ‘‘(B) a participant in the network established under subsection 319D(d). ‘‘(3) APPLICATION.—Each eligible entity desiring a grant under this subsection shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. ‘‘(4) USE OF FUNDS.— ‘‘(A) IN GENERAL.—An eligible entity described in paragraph (2)(A)(i) that receives a grant under this subsection shall use the funds awarded pursuant to such grant to carry out a pilot demonstration project to purchase and implement the use of advanced diagnostic medical equipment to analyze real-time clinical specimens for pathogens of public health or bioterrorism significance and report any results from such project to State, local, and tribal public health entities and the network established under section 319D(d). ‘‘(B) OTHER ENTITIES.—An eligible entity described in paragraph (2)(A)(ii) that receives a grant under this section shall use the funds awarded pursuant to such grant to— ‘‘(i) improve the early detection, surveillance, and investigative capabilities of poison control centers for chemical, biological, radiological, and nuclear events by training poison information personnel to improve
VerDate 14-DEC-2004
09:16 Jul 13, 2007
Jkt 059194
PO 00003
Frm 00320
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL003.109
APPS06
PsN: PUBL003
�
